http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005018604-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f928cb5f71480c5fadfbc40a433d97e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bb66d9373d09efad73c142762f6dfb00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
filingDate 2004-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_850b2a4b857b8e207ddac21ecce4e7cb
publicationDate 2005-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2005018604-A2
titleOfInvention Novel inhalation powder comprising the cgrp antagonist 1-[n2-[3,5-dibromo-n-[[4-(3,4-dihydro-2(1h)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-d-tyrosyl]-l-lysyl]-4-(4-pyridinyl)-piperazine
abstract The invention relates to a powder preparation for pulmonary or nasal inhalation, comprising the CGRP antagonist 1-[N<2>-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyridinyl)-piperazine (A), or a pharmaceutically-acceptable salt thereof, methods for production and use thereof for the production of a medicament for the treatment of headaches, migraines and cluster headaches.
priorityDate 2003-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005018603-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005018614-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03070215-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03070753-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005018609-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03015787-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129381420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10415276
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21663971
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3423265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402946
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228378078
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136460
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID134396547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7427
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918509
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399858
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439186
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413434
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129488327
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10467
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127700386
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1115
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6255
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414844
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405558
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8215
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405557
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID440995
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226679904
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127822818

Total number of triples: 52.